Suche
Mein Konto
Woman from Hof demands millions in compensation after vaccination damage!
A woman from Upper Franconia is suing Astrazeneca for vaccine damage after Covid vaccination. OLG Bamberg will decide on December 8, 2025.
Woman from Hof demands millions in compensation after vaccination damage!
What moves people’s minds in Upper Franconia? A 35-year-old woman from Hof took on the vaccine manufacturer Astrazeneca in court. On December 8, 2023, the Higher Regional Court in Bamberg will decide whether she will receive compensation for the serious consequences of an intestinal vein thrombosis that she suffered after being vaccinated with the Covid-19 vaccine “Vaxzevria”. Her demands are considerable: She is demanding at least 250,000 euros in compensation for pain and suffering, 17,200 euros for loss of earnings and up to 600,000 euros for future impairments.
The lawsuit alleges that the woman fell into a coma and lost part of her intestines after her vaccination in March 2021. The lawyer for those affected presents this as possible vaccination damage and a serious side effect of the Astrazeneca vaccine. The lawsuit at the Hof regional court had previously been dismissed in January 2023 because no product defect or lack of information could be proven. The appeal process has been running at the Bamberg Higher Regional Court since July 2023.
Clarification of side effects
The physical consequences for the woman are significant and cause deep wounds in her life. But she is not the only one struggling with serious side effects. AstraZeneca has now admitted that its vaccine “Vaxzevria” can have serious side effects. This finding comes from court documents in London and involves thrombosis with thrombocytopenia syndrome (TTS), which leads to blood clots and a reduced number of platelets. On March 24, 2021, the Paul Ehrlich Institute informed about these safety concerns in a Red Hand letter, whereupon the Standing Vaccination Commission (Stiko) only recommended vaccination with Astrazeneca for people over 60 years of age. The authorities thus addressed the problem of thromboembolic side effects, which predominantly occurred in younger women.
The Bamberg Higher Regional Court provided comprehensive information about the side effects, which ordered Astrazeneca to provide precise information about the side effects for the period from December 27, 2020 to February 19, 2024. This level of scrutiny could lead to support for further damages claims from individual plaintiffs, in addition to ongoing class actions in the UK.
A rude awakening for Astrazeneca?
In view of such developments, Astrazeneca is increasingly coming into focus. A quick look at the ongoing claims in London, where 51 cases are currently being heard, shows that the financial claims there are close to £100 million. These circumstances make it clear that the situation is not only a topic of discussion in Germany; Astrazeneca is also threatened with a rude awakening internationally. The problems surrounding the vaccine raise not only health but also legal questions that could become increasingly pressing in the coming months and years.
Whether the woman from Hof receives her compensation now depends on the decision of the Higher Regional Court. It already seems clear: the vaccination campaign, which had raised so many hopes, also has its downsides.